Chimeric antigen receptor (CAR) T cells overexpressing Bcl-xL increase proliferation and antitumor activity alone and in combination with BH3 mimetics

被引：1
|
作者：
Korell, Felix
Olson, Michael
Salas-Benito, Diego
Leick, Mark B.
Larson, Rebecca C.
Silva, Harrison
Gasparetto, Alessandro
Berger, Trisha R.
Bouffard, Amanda
Kann, Michael C.
Mergen, Markus
Kienka, Tamina
Wehrli, Marc
Bailey, Stefanie R.
Letai, Anthony
Maus, Marcela V.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4098
引用
收藏
页数：3
相关论文
共 13 条
  • [1] Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics
    Korell, Felix
    Olson, Michael L.
    Salas-Benito, Diego
    Leick, Mark B.
    Larson, Rebecca C.
    Bouffard, Amanda
    Silva, Harrison
    Gasparetto, Alessandro
    Berger, Trisha R.
    Kann, Michael C.
    Mergen, Markus
    Kienka, Tamina
    Wehrli, Marc
    Haradhvala, Nicholas J.
    Bailey, Stefanie R.
    Letai, Anthony
    Maus, Marcela V.
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (750)
  • [2] Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
    Abed, Mohammed Najim
    Abdullah, Marwan Ibrahim
    Richardson, Alan
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [3] Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
    Mohammed Najim Abed
    Marwan Ibrahim Abdullah
    Alan Richardson
    Journal of Ovarian Research, 9
  • [4] Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-XL in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients
    Beltran-Visiedo, Manuel
    Jimenez-Alduan, Nelia
    Diez, Rosana
    Cuenca, Marta
    Benedi, Andrea
    Serrano-Del Valle, Alfonso
    Azaceta, Gemma
    Palomera, Luis
    Peperzak, Victor
    Anel, Alberto
    Naval, Javier
    Marzo, Isabel
    MOLECULAR ONCOLOGY, 2023, 17 (12) : 2507 - 2525
  • [5] Novel CD3-Fusion Receptor enables combination of T-cell engagers and allogeneic CAR T cells to promote enhanced antitumor activity and overcome antigen
    Lu, Dan
    Peralta, Eigen
    Chu, Hui-Yi
    Park, Soo
    Tsuda, Masanao
    Avramis, Earl
    Denholtz, Matthew
    Witty, Alec
    Lee, Tom
    Valamehr, Bahram
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Generation of TIM3 inhibitory single-domain antibodies to boost the antitumor activity of chimeric antigen receptor T cells
    Yang, Liu
    Chen, Xin
    Wang, Qian
    Zhu, Yuankui
    Wu, Changfa
    Ma, Xuqian
    Zuo, Dianbao
    He, Huixia
    Huang, Le
    Li, Jingwen
    Xia, Chunjiao
    Hu, Sheng
    Yang, Xiaoqing
    Feng, Mingqian
    ONCOLOGY LETTERS, 2021, 22 (01)
  • [7] γc Cytokines IL7 and IL15 Expanded Chimeric Antigen Receptor-Redirected T Cells (CAR-T) with Superior Antitumor Activity In Vivo
    Xu, Yang
    Zhang, Ming
    Mahendravada, Aruna
    Savoldo, Barbara
    Dotti, Gianpietro
    MOLECULAR THERAPY, 2013, 21 : S20 - S21
  • [8] Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma
    Sakunrangsit, Nithidol
    Khuisangeam, Nattarika
    Inthanachai, Thananya
    Yodsurang, Varalee
    Taechawattananant, Pasrawin
    Suppipat, Koramit
    Tawinwung, Supannikar
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (06)
  • [9] Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma
    Liu, Ying
    Di, Shengmeng
    Shi, Bizhi
    Zhang, Honghong
    Wang, Yi
    Wu, Xiuqi
    Luo, Hong
    Wang, Huamao
    Li, Zonghai
    Jiang, Hua
    JOURNAL OF IMMUNOLOGY, 2019, 203 (01): : 198 - 207
  • [10] Rapamycin-resistant proliferation of CD8+T cells correlates with p27kip1 down-regulation and bcl-xL induction, and is prevented by an inhibitor of phosphoinositide 3-kinase activity
    Slavik, JM
    Lim, DG
    Burakoff, SJ
    Hafler, DA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (02) : 910 - 919
12